Leptin Corrects Increased Gene Expression of Renal 25-Hydroxyvitamin D 3-1α-Hydroxylase and -24-Hydroxylase in Leptin-Deficient, ob/ ob Mice

Endocrinology

Volumn 145, Issue 3, 2004, Pages 1367-1375

  Matsunuma, Ayako ^a   Kawane, Tetsuya ^a   Maeda, Toyonobu ^a   Hamada, Setsuo ^a   Horiuchi, Noboru ^a  

^a OHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

24,25 DIHYDROXYCOLECALCIFEROL; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL; CALCIUM; DEOXYPYRIDINOLINE; LEPTIN; PHOSPHATE; TESTOSTERONE; VITAMIN D RECEPTOR;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CELL; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; FEMUR; GENE EXPRESSION; HYPOGONADISM; KIDNEY CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOLYSIS; PHOSPHATE BLOOD LEVEL; PHOSPHATE EXCRETION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CALCITRIOL; CALCIUM; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMEOSTASIS; KIDNEY; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; PHOSPHORUS; STEROID HYDROXYLASES;

EID: 1442274634     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1010     Document Type: Article

References (60)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432
2. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543
3. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546
4. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P 1995 Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549
5. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S 1997 Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-908
6. Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB, Unger RH 1997 Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 94:4637-4641
7. Gainsford T, Willson TA, Metcalf D, Handman E, McFarlane C, Ng A, Nicola NA, Alexander WS, Hilton DJ 1996 Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci USA 93:14564-14568
8. + channels in pancreatic β-cells. Diabetes 46:1087-1093
9. Spicer LJ, Francisco CC 1997 The adipose obese gene product, leptin: evidence of a direct inhibitory role in ovarian function. Endocrinology 138:3374-3379
10. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros JR 1998 Biological action of leptin as an angiogenic factor. Science 281:1683-1686
11. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295
12. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI 1995 Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263-1271
13. Luheshi GN, Gardner JD, Rushforth DA, Loudon AS, Rothwell NJ 1999 Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci USA 96:7047-7052
14. Casanueva FF, Dieguez C 1999 Neuroendocrine regulation and actions of leptin. Front Neuroendocrinol 20:317-363
15. Morton NM, Emilsson V, Liu YL, Cawthorne MA 1998 Leptin action in intestinal cells. J Biol Chem 273:26194-26201
16. Seufert J, Kieffer TJ, Habener JF 1999 Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc Natl Acad Sci USA 96:674-679
17. Riggs BL, Melton III LJ 1992 The prevention and treatment of osteoporosis. N Engl J Med 327:620-627
18. Slemenda CW, Hui SL, Longcope C, Wellman H, Johnston Jr CC 1990 Predictors of bone mass in perimenopausal women. A prospective study of clinical data using photon absorptiometry. Ann Intern Med 112:96-101
19. Glauber HS, Vollmer WM, Nevitt MC, Ensrud KE, Orwoll ES 1995 Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. J Clin Endocrinol Metab 80:1118-1123
20. Revilla M, Villa LF, Hernandez ER, Sanchez-Atrio A, Cortes J, Rico H 1997 Influence of weight and gonadal status on total and regional bone mineral content and on weight-bearing and non weight-bearing bone, measured by dual-energy x-ray absorptiometry. Maturitas 28:69-74
21. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357
22. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197-207
23. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G 2002 Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-317
24. Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG 2000 Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 92:73-78
25. Burguera B, Hofbauer LC, Thomas T, Gori F, Evans GL, Khosla S, Riggs BL, Turner RT 2001 Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142:3546-3553
26. Khosla S 2002 Leptin-central or peripheral to the regulation of bone metabolism? Endocrinology 143:4161-4164
27. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW 1998 The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349
28. Sutton AL, MacDonald PN 2003 Vitamin D: more than a "bone-a- fide" hormone. Mol Endocrinol 17:777-791
29. Kawane T, Takahashi S, Saitoh H, Okamoto H, Kubodera N, Horiuchi N 2002 Anabolic effects of recombinant human parathyroid hormone (1-84) and synthetic human parathyroid hormone (1-34) on the mandibles of osteopenic ovariectomized rats with maxillary molar extraction. Horm Metab Res 34:293-302
30. Iwasaki Y, Yamato H, Murayama H, Sato M, Takahashi T, Ezawa I, Kurokawa K, Fukagawa M 2003 Combination use of vitamin K(2) further increases bone volume and ameliorates extremely low turnover bone induced by bisphosphonate therapy in tail-suspension rats. J Bone Miner Metab 21:154-160
31. 3. Endocrinology 138:2233-2240
32. 3 1α-hydroxylase and vitamin D synthesis. Science 277:1827-1830
33. 3. Endocrine 17:109-118
34. Akeno N, Matsunuma A, Maeda T, Kawane T, Horiuchi N 2000 Regulation of vitamin D-1α-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney. J Endocrinol 164:339-348
35. Lobaugh B, Drezner MK 1983 Measurement of 25-hydroxyvitamin D-1 α-hydroxylase activity in mammalian kidney. Anal Biochem 129:416-424
36. Thomas T, Burguera B, Melton III LJ, Atkinson EJ, O'Fallon WM, Riggs BL, Khosla S 2001 Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 29:114-120
37. Liu C, Grossman A, Bain S, Strachan M, Puemer D, Bailey C, Humes J, Lenox J, Yamamoto G, Sprugel K, Kuiiper J, Weigle S, Dumam D, Moore E 1997 Leptin stimulates cortical bone formation in obese (ob/ob) mice. J Bone Miner Res 12(Suppl 1):S115
38. Lorentzon R, Alehagen U, Boquist L 1986 Osteopenia in mice with genetic diabetes. Diabetes Res Clin Pract 2:157-163
39. Tamasi JA, Arey BJ, Bertolini DR, Feyen JH 2003 Characterization of bone structure in leptin receptor-deficient Zucker (fa/fa) rats. J Bone Miner Res 18:1605-1611
40. Thomas T, Gori F, Spelsberg TC, Khosla S, Riggs BL, Conover CA 1999 Response of bipotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes. Endocrinology 140:5036-5044
41. Lollmann B, Gruninger S, Stricker-Krongrad A, Chiesi M 1997 Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and, e in different mouse tissues. Biochem Biophys Res Commun 238:648-652
42. Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO, Drevon CA 2001 Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16:1426-1433
43. Gordeladze JO, Drevon CA, Syversen U, Reseland JE 2002 Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 85:825-836
44. Maor G, Rochwerger M, Segev Y, Phillip M 2002 Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J Bone Miner Res 17:1034-1043
45. Holloway WR, Collier FM, Aitken CJ, Myers DE, Hodge JM, Malakellis M, Gough TJ, Collier GR, Nicholson GC 2002 Leptin inhibits osteoclast generation. J Bone Miner Res 17:200-209
46. Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E 1997 Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 82:2386-2390
47. Vanderschueren D, Vandenput L, Boonen S, Van Herck E, Swinnen JV, Bouillon R 2000 An aged rat model of partial androgen deficiency: prevention of both loss of bone and lean body mass by low-dose androgen replacement. Endocrinology 141:1642-1647
48. Mounzih K, Lu R, Chehab FF 1997 Leptin treatment rescues the sterility of genetically obese ob/ob males. Endocrinology 138:1190-1193
49. Ewart-Toland A, Mounzih K, Qiu J, Chehab FF 1999 Effect of the genetic background on the reproduction of leptin-deficient obese mice. Endocrinology 140:732-738
50. 3 synthesis in rats. Endocrinology 101:969-974
51. 3 in intact animals. Endocrinology 140:2224-2231
52. 3 by a mechanism involving adenosine 3′, 5′- monophosphate in rats. Endocrinology 118:1583-1589
53. Maffei M, Fei H, Lee GH, Dani C, Leroy P, Zhang Y, Proenca R, Negrel R, Ailhaud G, Friedman JM 1995 Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc Natl Acad Sci USA 92:6957-6960
54. Fei H, Okano HJ, Li C, Lee GH, Zhao C, Darnell R, Friedman JM 1997 Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci USA 94:7001-7005
55. Jackson EK, Li P 1997 Human leptin has natriuretic activity in the rat. Am J Physiol 272:F333-F338
56. Zeng J, Patterson BW, Klein S, Martin DR, Dagogo-Jack S, Kohrt WM, Miller SB, Landt M 1997 Whole body leptin kinetics and renal metabolism in vivo. Am J Physiol 273:E1102-E1106
57. 3-24-hydroxylase. J Bone Miner Res 10:1951-1959
58. Considine RV, Caro JF 1999 Pleiotropic cellular effects of leptin. Curr Opin Endocrinol Diabetes 6:163-169
59. Horwood NJ, Elliott J, Martin TJ, Gillespie MT 1998 Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139:4743-4746
60. Delmas PD 1993 Biochemical markers of bone turnover. J Bone Miner Res Suppl 2:S549-S555